Last reviewed: July 9, 2026

Last updated: July 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy comes in pre-filled pens with fixed doses, and patients typically progress through a four-step dose escalation over 16 weeks before reaching their maintenance level. Understanding how many pens you'll need each month helps clarify your weight loss medication timeline and budget. PlexusDx provides a transparent alternative with compounded semaglutide injections at flat monthly pricing, starting at $189/mo (or $149/mo on the 6-month plan).

Standard Wegovy Pen Quantities and Dose Progression

Wegovy's standard dosing protocol begins at 0.25 mg weekly for the first four weeks, then increases every four weeks: 0.5 mg, 1.0 mg, 1.7 mg, and finally 2.4 mg for ongoing weight management. Each pre-filled pen typically delivers one weekly injection, meaning patients use approximately four to five pens per month depending on their current dose tier. The escalation phase alone spans 16 weeks, during which patients might use between eight and twelve total pens before reaching the 2.4 mg maintenance dose.

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Wegovy or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Why Compounded Semaglutide Offers Clearer Pricing Than Brand Pens

Brand-name Wegovy pricing varies based on dose level and pharmacy, creating confusion about true monthly costs as patients escalate through the dosing schedule. PlexusDx compounded semaglutide injections eliminate this complexity with flat monthly pricing at $189 per month—your dose may need to go up, but your price won't. This transparent approach allows patients to plan their weight loss therapy budget without unexpected increases when advancing to higher therapeutic doses.

Compounded medications prepared by licensed 503A compounding pharmacies meet the same FDA manufacturing standards as brand products, ensuring consistency and safety. PlexusDx serves all 50 states without requiring insurance or membership fees, making personalized semaglutide therapy accessible to patients who face barriers with traditional pharmacy channels. Choosing compounded semaglutide means predictable costs aligned with your medical needs rather than escalating pharmaceutical pricing.

How Genetic Testing Helps Optimize Your Semaglutide Response

Not all patients respond identically to semaglutide, and individual genetic variations influence how effectively your body processes GLP-1 medications. The PlexusDx Precision Peptide Genetic Test examines key genetic variants including GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609, which directly affect your body's peptide signaling pathways and weight regulation capacity. Understanding your genetic blueprint allows your healthcare provider to personalize your starting dose, escalation pace, and expected response timeline rather than following a one-size-fits-all protocol.

The test maps 14 distinct metabolic pathways and 150+ genetic insights, revealing whether you're a rapid responder who may reach effective doses faster or require a more gradual escalation to minimize side effects. Patients with specific genetic predispositions may benefit from alternative compounds like tirzepatide or the dual-compound GLP-Squared injection, which activates additional peptide pathways. Genetic guidance transforms your treatment from standard dosing into precision therapy tailored to your unique physiology.

Managing Monthly Costs and Commitment Tiers at PlexusDx

PlexusDx structures semaglutide injections on three commitment tiers starting at $189/mo (or $149/mo on the 6-month plan), with pricing remaining flat regardless of your escalating dose level. Unlike traditional pharmacies where Wegovy costs spike at higher doses, PlexusDx patients enjoy consistent budgeting across their entire treatment journey from initiation through long-term weight maintenance. The Precision Peptide Genetic Test costs $99 and is available as an add-on after your first month of treatment, providing personalized insights to optimize outcomes.

PlexusDx medications are HSA and FSA eligible, allowing patients to use pre-tax healthcare savings accounts for treatment costs. No insurance verification is required, no monthly membership fees apply, and prescriptions can be filled across all 50 states. These features make compounded semaglutide therapy more accessible and affordable than navigating insurance coverage for brand-name Wegovy, especially for uninsured patients or those with high deductibles.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $189/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How many Wegovy pens do I need per month?

Most patients use four to five Wegovy pens monthly, with the exact count varying by dose tier and escalation phase. During the initial 16-week escalation, patients progress through increasing doses requiring different pen quantities. PlexusDx compounded semaglutide simplifies this by offering flat monthly pricing, eliminating confusion about pen counts and dose-based cost increases.

Is compounded semaglutide as effective as brand-name Wegovy?

Compounded semaglutide from licensed 503A pharmacies contains the identical active pharmaceutical ingredient and meets the same manufacturing standards as brand products. Clinical efficacy depends on proper dosing, patient adherence, and individual genetic factors rather than whether medication is brand or compounded. PlexusDx's Precision Peptide Genetic Test helps personalize therapy to maximize your individual response.

What's the actual monthly cost of PlexusDx semaglutide injections?

PlexusDx compounded semaglutide injections start at $189/mo (or $149/mo on the 6-month plan) across all three commitment tiers, with pricing remaining flat as your dose increases. This transparent structure eliminates surprise cost jumps when advancing through dose escalation phases. HSA and FSA accounts are eligible, and no insurance is required for access.

What side effects should I expect with semaglutide dose escalation?

Common side effects include nausea, vomiting, constipation, and reduced appetite, which typically decrease as your body adjusts over one to two weeks at each dose level. Genetic factors influence side effect severity and tolerance, which is why the PlexusDx Precision Peptide Genetic Test can inform your provider about whether slower escalation might benefit you. Severe or persistent side effects warrant immediate contact with your prescribing clinician.

How does the PlexusDx genetic test improve my semaglutide outcomes?

The Precision Peptide Genetic Test identifies your individual variations in GLP1R, GIPR, FTO, and MC4R genes, which control how effectively semaglutide activates weight loss pathways in your body. This $99 test, added after your first treatment month, reveals whether you're genetically predisposed to rapid response, side effect sensitivity, or need for alternative compounds like tirzepatide. Genetic guidance enables your provider to customize your dose schedule and compound selection for optimal weight loss results.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves